These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38271927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
    Mavrogianni C, Lambrinou CP, Androutsos O, Lindström J, Kivelä J, Cardon G, Huys N, Tsochev K, Iotova V, Chakarova N, Rurik I, Moreno LA, Liatis S, Makrilakis K, Manios Y, Feel4Diabetes-study group.
    Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA, Burgos-Lunar C, Lahoz C, Mostaza JM, Abánades-Herranz JC, Laguna-Cuesta F, Estirado-de Cabo E, García-Iglesias F, González-Alegre T, Fernández-Puntero B, Montesano-Sánchez L, Vicent-López D, Cornejo-Del Río V, Fernández-García PJ, Sánchez-Arroyo V, Sabín-Rodríguez C, López-López S, Patrón-Barandio P, Gómez-Campelo P, SPREDIA-2 Group.
    PLoS One; 2016 Apr; 11(7):e0158489. PubMed ID: 27441722
    [Abstract] [Full Text] [Related]

  • 7. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E, Sigurðardóttir ÁK, Graue M, Kolltveit BH, Skinner T.
    BMC Public Health; 2023 Jan 31; 23(1):211. PubMed ID: 36721135
    [Abstract] [Full Text] [Related]

  • 8. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM, Chia YC, Koay ZL.
    Prim Care Diabetes; 2020 Oct 31; 14(5):494-500. PubMed ID: 32156516
    [Abstract] [Full Text] [Related]

  • 9. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
    Gabriel R, Acosta T, Florez K, Anillo L, Navarro E, Boukichou N, Acosta-Reyes J, Barengo NC, Lindström J, Tuomilehto JO, Aschner P.
    Diabetes Res Clin Pract; 2021 Aug 31; 178():108976. PubMed ID: 34302911
    [Abstract] [Full Text] [Related]

  • 10. Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population.
    Gannar F, Rodriguez-Pérez MDC, Domínguez Coello S, Haouet K, Brito Díaz B, Cabrera de León A.
    PLoS One; 2018 Aug 31; 13(8):e0200718. PubMed ID: 30110336
    [Abstract] [Full Text] [Related]

  • 11. Identifying Adult Population at Risk for Undiagnosed Diabetes Mellitus in Medan City, Indonesia Targeted on Diabetes Prevention.
    Siregar FA, Asfriyati, Makmur T, Bestari R, Lubis IA, Zein U.
    Med Arch; 2023 Aug 31; 77(6):455-459. PubMed ID: 38313111
    [Abstract] [Full Text] [Related]

  • 12. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J, Bergmann A, Reimann M, Bornstein SR, Schwarz PE.
    Horm Metab Res; 2009 Feb 31; 41(2):98-103. PubMed ID: 18975253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Developing a risk score for undiagnosed prediabetes or type 2 diabetes among Saharawi refugees in Algeria.
    Henjum S, Hjellset VT, Andersen E, Flaaten MØ, Morseth MS.
    BMC Public Health; 2022 Apr 11; 22(1):720. PubMed ID: 35410198
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ, de Burgos-Lunar C, Mostaza Prieto J, Lahoz Rallo C, Abánades-Herranz JC, Gómez-Campelo P, Laguna Cuesta F, Estirado De Cabo E, García Iglesias F, González Alegre T, Fernández Puntero B, Montesano Sánchez L, Vicent López D, Cornejo Del Río V, Fernández García PJ, Sabín Rodríguez C, López López S, Patrón Barandío P, SPREDIA-2 Group.
    BMJ Open; 2015 Jul 28; 5(7):e007195. PubMed ID: 26220868
    [Abstract] [Full Text] [Related]

  • 17. HbA1c presents low sensitivity as a post-pregnancy screening test for both diabetes and prediabetes in Greek women with history of gestational diabetes mellitus.
    Apostolakis M, Paschou SA, Zapanti E, Sarantopoulou V, Vasileiou V, Anastasiou E.
    Hormones (Athens); 2018 Jun 28; 17(2):255-259. PubMed ID: 29949125
    [Abstract] [Full Text] [Related]

  • 18. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC, Lima-Martínez MM, Nava A, Trerotola G, Paoli M, Cabrera-Rego JO, Gonzalez B, Arciniegas A, Paez J.
    Med Princ Pract; 2019 Jun 28; 28(4):324-332. PubMed ID: 30852570
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.